Information  X 
Enter a valid email address

EPIC/TIDM matching '0JGL'

Date
Time Source
Company
Announcement
23 Nov 2020 7:30 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Successful Phase I fimaVacc vaccination proof of concept study to be published in Frontiers in Immunology
16 Nov 2020 7:30 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: European patent for treatment of bile duct cancer with the fimaChem technology
11 Nov 2020 6:00 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech third quarter 2020 results
26 Oct 2020 11:47 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: First patient enrolled in Asia in the fimaCHEM pivotal RELEASE study
21 Oct 2020 7:30 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Preclinical research collaboration with big pharma ended
06 Oct 2020 2:01 pm GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Employee share option scheme
08 Sep 2020 11:00 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Capital increase registered and listing of new shares
02 Sep 2020 5:14 pm GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Exercise of employee share options, mandatory notification of trade and resolution to increase share capital
01 Sep 2020 8:00 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech announce a research collaboration with DCprime to explore novel cancer vaccination concepts
26 Aug 2020 6:00 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: First half-year 2020 results
19 Aug 2020 8:21 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Invitation to second quarter and first half 2020 results presentation
  7:22 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Publication of case report series from the Phase I study in bile duct cancer
13 Jul 2020 6:31 pm GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Update on the preclinical research collaboration agreement with AstraZeneca
27 May 2020 11:04 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Minutes from Annual General Meeting 2020
26 May 2020 12:20 pm GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Disclosure of voting rights for Chairman of the Board
06 May 2020 10:00 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Notice of Annual General Meeting 2020
  6:00 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: First quarter 2020 results
30 Apr 2020 8:54 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech appoints Mr Ludovic Robin as Chief Business Officer
28 Apr 2020 12:00 pm GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Invitation to Q1 2020 results presentation
22 Apr 2020 7:00 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech Holding ASA publishes the Annual Report 2019
31 Mar 2020 7:00 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech appoints Dr Amir Snapir as Chief Medical Officer
26 Mar 2020 8:12 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: US patent for the vaccine technology (fimaVacc) with a new important class of adjuvants
25 Mar 2020 9:06 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Update on operational implications of the corona pandemic
26 Feb 2020 6:00 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech's fourth quarter and preliminary 2019 results
19 Feb 2020 12:38 pm GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Invitation to fourth quarter and preliminary 2019 results presentation
21 Jan 2020 7:00 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: US patent granted for the vaccine technology (fimaVacc) in combination with cytokines
12 Dec 2019 7:00 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech to present Phase I fimaVacc results at ESMO Immuno-Oncology 2019
27 Nov 2019 6:00 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Third quarter 2019 results
26 Nov 2019 5:10 pm GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Expansion of preclinical research collaboration agreement with AstraZeneca
19 Nov 2019 2:00 pm GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech to present at Jefferies 2019 London Healthcare Conference
  9:15 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Invitation to third quarter 2019 results presentation
12 Nov 2019 2:11 pm GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech to present at BIO-Europe 2019
28 Oct 2019 3:00 pm GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech to present at World Vaccine Congress Europe
18 Oct 2019 1:59 pm GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Mandatory notification regarding trade of shares
09 Sep 2019 6:00 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Capital increase registered and listing of new shares
04 Sep 2019 4:01 pm GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Exercise of employee share options, mandatory notification of trade and resolution to increase share capital
29 Aug 2019 5:00 pm GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Mandatory notification regarding trade of shares
28 Aug 2019 6:00 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Second quarter and first half 2019 results
20 Aug 2019 2:38 pm GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Invitation to second quarter and first half 2019 results presentation
22 Jul 2019 7:00 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Extension of preclinical research collaboration agreement with a top-10 large pharma company
01 Jul 2019 1:52 pm GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech to present at IPA World Congress
21 Jun 2019 2:00 pm GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Employee share option scheme
29 May 2019 11:11 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Minutes from Annual General Meeting 2019
28 May 2019 2:26 pm GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Disclosure of voting rights for Chairman of the Board
23 May 2019 9:06 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: First patient enrolled in the fimaChem pivotal RELEASE study
08 May 2019 10:00 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Notice of Annual General Meeting 2019
  6:30 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: First quarter 2019 results
02 May 2019 5:57 pm GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Successful clinical translation of the fimaVacc technology
30 Apr 2019 10:13 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Invitation to first quarter 2019 result presentation
09 Apr 2019 9:06 pm GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Annual Report 2018
08 Apr 2019 9:32 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Final confirmation of successful safety read-out in the Phase I Extension study
28 Feb 2019 3:33 pm GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Resignation of Chief Business Development Officer
25 Feb 2019 9:53 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Capital increase registered and listing of new shares
20 Feb 2019 5:17 pm GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Exercise of employee share options, mandatory notification of trade and resolution to increase share capital
13 Feb 2019 6:30 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Fourth quarter and preliminary 2018 results
05 Feb 2019 12:56 pm GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Invitation to fourth quarter and preliminary 2018 result presentation
20 Dec 2018 7:00 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Preliminary confirmation of safety read-out from the fimaChem Phase I extension study in bile duct cancer
18 Dec 2018 1:55 pm GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Extension of preclinical research collaboration agreement with a top-10 large pharma company
13 Nov 2018 6:30 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Third quarter 2018 results
06 Nov 2018 7:00 am GNW Factsheet PCI Biotech Holding ASA (0JGL) PCI Biotech: Invitation to third quarter 2018 presentation


Company Announcements Archive »

 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t